Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gibofsky

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Annals of Internal Medicine|October 1, 1982
Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritisT M Parris, R P Kimberly, R D Inman, et al.
Nature|March 8, 1979
Association of a B-cell alloantigen with susceptibility to rheumatic feverM E Patarroyo, R J Winchester, A Vejerano, et al.
Arthritis and Rheumatism|May 1, 1981
Three siblings with scleroderma (systemic sclerosis) and two with Raynaud's phenomenon from a single kindredW B Sheldon, D P Lurie, H R Maricq, et al.
Osteoarthritis and Cartilage|March 15, 2011
Outcome measures in placebo-controlled trials of osteoarthritis: responsiveness to treatment effects in the REPORT databaseR H Dworkin, S Peirce-Sandner, D C Turk, et al.
Annals of the Rheumatic Diseases|April 15, 2004
Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritisT Pincus, G Koch, H Lei, et al.
Arthritis and Rheumatism|June 1, 1978
Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosusA Gibofsky, R Winchester, J Hansen, et al.
The Journal of Clinical Investigation|May 1, 1989
Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibodyA K Khanna, D R Buskirk, R C Williams, et al.
Osteoarthritis and Cartilage|February 15, 2021
A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritisY Yazici, T E McAlindon, A Gibofsky, et al.
Osteoarthritis and Cartilage|July 17, 2017
A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 studyY Yazici, T E McAlindon, R Fleischmann, et al.
Annals of the Rheumatic Diseases|October 9, 2003
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)D E Furst, F C Breedveld, J R Kalden, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Annals of Internal Medicine|October 1, 1982
Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritisT M Parris, R P Kimberly, R D Inman, et al.
Nature|March 8, 1979
Association of a B-cell alloantigen with susceptibility to rheumatic feverM E Patarroyo, R J Winchester, A Vejerano, et al.
Arthritis and Rheumatism|May 1, 1981
Three siblings with scleroderma (systemic sclerosis) and two with Raynaud's phenomenon from a single kindredW B Sheldon, D P Lurie, H R Maricq, et al.
Osteoarthritis and Cartilage|March 15, 2011
Outcome measures in placebo-controlled trials of osteoarthritis: responsiveness to treatment effects in the REPORT databaseR H Dworkin, S Peirce-Sandner, D C Turk, et al.
Annals of the Rheumatic Diseases|April 15, 2004
Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritisT Pincus, G Koch, H Lei, et al.
Arthritis and Rheumatism|June 1, 1978
Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosusA Gibofsky, R Winchester, J Hansen, et al.
The Journal of Clinical Investigation|May 1, 1989
Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibodyA K Khanna, D R Buskirk, R C Williams, et al.
Osteoarthritis and Cartilage|February 15, 2021
A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritisY Yazici, T E McAlindon, A Gibofsky, et al.
Osteoarthritis and Cartilage|July 17, 2017
A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 studyY Yazici, T E McAlindon, R Fleischmann, et al.
Annals of the Rheumatic Diseases|October 9, 2003
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)D E Furst, F C Breedveld, J R Kalden, et al.
Pageof 7